TCS Life Sciences and Healthcare

Clinical trials are evolving rapidly, and quality oversight must evolve with them. Moving away from traditional approaches is our advanced @TCS ADD™ Risk Based Quality Management platform. The platform’s AI and advanced analytics capabilities reimagine how clinical trials are monitored and managed. With interoperable modules, AI-driven analytics, and streamlined workflows, the enhanced platform offers a unified way to manage risk, quality tolerance limits, centralized monitoring, and subject-level insights. It also aligns with emerging regulatory expectations and embeds Quality by Design(QbD) principles throughout the study lifecycle. For organizations aiming to increase predictability, reduce oversight complexity, and achieve stronger study outcomes, this represents a significant step forward. Read more: https://lnkd.in/dmZYzA3T To schedule a meeting with our product experts, write to us at add.platform@tcs.com. Tata Consultancy Services Rachna Malik | Narayanan Ramaswamy | Saurabh Das | Anumita Ghosal | Meenu Sarda #TCS #TCSADD #AI #TransformingCare #ImpactingLivesTogether #Clinicaltrials #RBQM #LifeSciences

The PHUSE SDE in Bengaluru on Saturday, November 22, 2025, where Tata Consultancy Services proudly served as a Gold Sponsor, was a resounding success—bringing together the global healthcare data science community to share ideas, tools, and standards shaping the future of life sciences. Key discussions highlighted the growing impact of AI in clinical research, including: - Applying AI/ML methodologies in clinical trials - Leveraging open-source technologies for data analysis and reporting - Driving data transparency and sharing - Unlocking the transformative potential of real-world data (RWD) Shashibala Bhojani, Head of Value Office, Life Sciences at TCS, delivered an inspiring keynote on the “Intelligence Shift Using AI” and its role in revolutionizing clinical development. The PHUSE event proved to be an excellent forum for exchanging ideas and gaining fresh perspectives. TCS was delighted to contribute and collaborate with industry leaders. #TCS #TransformingCare #ImpactingLivesTogether #PHUSE

QIAGEN, a global leader in molecular research and testing, wanted to unlock the transformative potential of Generative AI across its workforce. The goal? Move beyond isolated solutions and make AI accessible to every employee. Partnering with Tata Consultancy Services, QIAGEN rolled out Microsoft 365 Copilot in a secure, compliant, and scalable way—accelerating adoption and driving real impact: - 25% workforce adoption within a regulated environment - 87% users reported time savings or improved work quality - Seamless integration across core workflows—from R&D to sales and quality assurance This initiative is reshaping how teams collaborate, analyze data, and make decisions, marking a major milestone in QIAGEN’s digital transformation journey. Read: https://lnkd.in/dVSp9H-g #TCS #TransformingCare #ImpactingLivesTogether #CustomerSpotlight

Tata Consultancy Services is proud to be a Gold Sponsor at the upcoming PHUSE event on November 22, 2025, hosted at Eli Lilly office, Bengaluru, India. This event will focus on AI/ML and robotics in clinical data science—exploring challenges, regulations, and best practices shaping the future of healthcare innovation. We’re excited that Shashibala Bhojani, Head of Value Office, Life Sciences Domain at TCS, will deliver the keynote on why clinical data science transformation is critical and how it enables data-driven decision-making in clinical development. PHUSE brings together the global healthcare data science community, offering networking, knowledge-sharing, and collaboration opportunities. Know more: https://lnkd.in/dJg6cz39 #TCS #TransformingCare #ImpactingLivesTogether #PHUSE

Personalised healthcare includes using your unique genetic and health data to tailor treatments and care plans specifically for you. With the advancement of multi-omics technologies, sophisticated data analytics, and artificial intelligence, the potential for personalised medicine is becoming brighter, allowing for a deeper understanding of individual diseases and the development of tailored treatment approaches. We’re curious—what interests you most about personalised healthcare? Vote in the poll below and share your thoughts in the comments! #TCS #TransformingCare #ImpactingLivesTogether #WhatsTheBeat

Welcome to the “60 seconds with the Expert" series .We’re thrilled to kick off the series with Amit Saxena, Global Head of Genomics & Digital Research at Tata Consultancy Services — a visionary leader driving innovation at the intersection of science and AI. From establishing TCS’s first DNA sequencing lab in India to spearheading initiatives in precision oncology, AI-driven drug discovery, and translational research, Amit’s work is shaping the future of hyper-personalized healthcare. He is a recognized inventor and thought leader, with multiple patents and industry accolades — including being a four-time winner of Tata Innovista.   In just 60 seconds, Amit shares his perspective on genomics, precision medicine, and the Cancer Research Center — a glimpse into the future of healthcare. Got questions for Amit or thoughts on the topic? Drop them in the comments — we’d love to hear from you! #60SecondsWithTheExpert #TCS #TransformingCare #ImpactingLivesTogether

We're thrilled to be at PHUSE EU Connect 2025 16–19 November | Congress Center Hamburg, Germany   Our Tata Consultancy Services ADD™ experts will be presenting a paper titled: “Revolutionizing Clinical Trial Monitoring and Data Analysis with AR and VR-driven Immersive Analytics.”   The paper explores how AR and VR can reshape the future of clinical trial monitoring and data interpretation. It highlights: • Immersive 3D exploration of clinical trial data for deeper insights • Faster identification of patient safety risks and operational issues • Spatially intuitive analytics across global trial sites • Proactive, real-time visualizations supporting risk-based quality management   These insights represent TCS’s commitment to advancing modern clinical operations and empowering medical monitors with next-gen tools.   Want to connect or book a demo? Email us at add.platform@tcs.com Rachna Malik | Narayanan Ramaswamy | Anumita Ghosal | Saurabh Das | Sushil Singh | Tej Narayan Yadav | Rajasekhar Gadde | Shubham Priyadarshi | Niketan Panchal | Rohit K. #TCS #TransformingCare #ImpactingLivesTogether #TCSADD

Advanced digital tools and technologies can reshape and accelerate technology transfer, shortening launch and approval cycles, improving first-time-right outcomes, driving operational excellence, enhancing regulatory confidence, and enhancing user experience. Join Tata Consultancy Services’ Life Sciences Virtual Roundtable ‘AI-enabled pharma tech transfer transformation’, featuring a panel of eminent industry leaders: · Dr. Yash Sabharwal, Co-founder and CEO, QbDVision · Dr. Gang X., Senior Director, Johnson & Johnson ·        Tom Mistretta, Director, Data Science, Amgen ·        Vinesh Balakrishnan Yezhuvath, Industry Advisor, Life Sciences, TCS ·        Sanjeev Sachdeva, Global Head - Advisory and Business Process Services, Life Sciences, TCS (Keynote) ·        Jai Sharma, Marketing Head, Life Sciences, TCS (Host) Date: November 12, 2025 Time: 9:00 AM ET | 2:00 PM GMT | 3:00 PM CET | 7:30 PM IST Key takeaways: · Explore challenges with traditional technology transfers in pharma, involving multiple stakeholders and documents to fragmented, siloed data and tacit knowledge. · Delve into how digital tools — ranging from electronic lab notebooks and recipe management systems to digital twins, artificial intelligence (AI), machine learning (ML), analytics, and regulatory information management — can reshape these processes. · Understand how this digitalization enables digital capture of tacit knowledge, standards-based data and connectivity, digital models and twins, advanced analytics and AI, risk-based transfer, and repeatable execution models. · Gain insights on a roadmap for digitalizing these processes, from early development through lifecycle management, unlocking both operational excellence and competitive advantage. Tune in to discover how digital tools can reshape technology transfer in the pharmaceutical industry! #TCS #TransformingCare #ImpactingLivesTogether #TCSLifeSciences #PharmaManufacturing #AI #DigitalTechnologies

From multiple stakeholders and documents to fragmented, siloed data, the challenges with traditional pharma tech transfers are multifold. Digital tools and technologies, including digital twins, artificial intelligence (AI), machine learning (ML), and analytics, can reshape and accelerate these processes. Join us for today’s roundtable as our esteemed panel of industry experts discuss how this digitalization enables the digital capture of tacit knowledge, standards-based data and connectivity, digital models and twins, risk-based transfer, and repeatable execution models. With a roadmap for digitalizing these processes, from early development through lifecycle management, organizations can unlock both operational excellence and competitive advantage. Tune in today, November 12, 2025, at 9:00 AM ET | 2:00 PM GMT | 3:00 PM CET | 7:30 PM IST Register now: https://lnkd.in/djKQe2vV This power-packed session features: Dr. Yash Sabharwal , Co-founder and CEO, QbDVision Dr. Gang X., Senior Director, Johnson & Johnson Tom Mistretta, Director, Data Science, Amgen Sanjeev Sachdeva, Global Head - Advisory and Business Process Services, Life Sciences, Tata Consultancy Services (Keynote) Vinesh Balakrishnan Yezhuvath, Industry Advisor, Life Sciences, Tata Consultancy Services Jai Sharma, Marketing Head, Life Sciences, Tata Consultancy Services (Host) #TCS #TransformingCare #ImpactingLivesTogether #TCSLifeSciences #PharmaManufacturing #AI #DigitalTechnologies

What an incredible experience at the World Drug Safety Congress Americas 2025! From thought-provoking discussions on the future of pharmacovigilance to inspiring insights shared by Sanjeev Sachdeva and Alejandra Guerchicoff, Ph.D. at Tata Consultancy Services, this year’s event in Boston was a true testament to how AI is transforming drug safety operations across the life sciences industry. Session details: • Keynote Panel – Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation • AI & Automation Track – Gen-AI: The Frontier of a Transformative PV Change At Booth #407, the energy was palpable as our live demos showcased how TCS is helping global life sciences organizations reimagine pharmacovigilance with next-gen AI and data science. A heartfelt thank you to everyone who stopped by, joined our sessions, and connected with our experts. Together, we’re shaping the next chapter of pharmacovigilance through innovation, intelligence, and impact. To schedule a meeting with our product experts, write to us at add.platform@tcs.com To read more about the platform visit: https://lnkd.in/dXgZPgDs Tata Consultancy Services - North America Rachna Malik | Narayanan Ramaswamy | Prithwiraj Ghosh | Vikas Jain | Amit Bajaj | Anumita Ghosal | Meenu Sarda #TCS #TransformingCare #ImpactingLivesTogether #TCSADD #Pharmacovigilance #AIinPV #LifeSciences #TCSatWDSC2025